Logo

GeneTrace Acquires Strata Biosciences, Closes Financing

Mar 24, 2000
Premium

A

LAMEDA, Calif.--GeneTrace Systems said it has completed its acquisition of Strata Biosciences, a genomics company with proprietary gene knockout technologies and cell-based assays for gene discovery, drug target identification, and validation. GeneTrace adds these technologies to its integrated Systems Biology platform of genomic, proteomic, and bioinformatic technologies for the discovery of new and more effective human therapeutics. GeneTrace closed a Series B financing in conjunction with the acquisition. The companies have consolidated their business operations at GeneTrace’s facilities here.

Filed under

Informatics
Breaking News
The Scan

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.

Tumor Microenvironment Immune Score Provides Immunotherapy Response, Prognostic Insights

Using multiple in situ analyses and RNA sequence data, researchers in eBioMedicine have developed a score associated with immunotherapy response or survival.

CRISPR-Based Method for Finding Cancer-Associated Exosomal MicroRNAs in Blood

A team from China presents in ACS Sensors a liposome-mediated membrane fusion strategy for detecting miRNAs carried in exosomes in the blood with a CRISPR-mediated reporter system.

Drug Response Variants May Be Distinct in Somatic, Germline Samples

Based on variants from across 21 drug response genes, researchers in The Pharmacogenomics Journal suspect that tumor-only DNA sequences may miss drug response clues found in the germline.